Canada markets closed

SciClone Pharmaceuticals (Holdings) Limited (SCCPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.83010.0000 (0.00%)
At close: 01:32PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
3,155,614
3,155,614
2,749,681
2,518,474
1,918,562
Cost of Revenue
799,413
799,413
679,196
585,468
428,106
Gross Profit
2,356,201
2,356,201
2,070,485
1,933,006
1,490,456
Operating Expenses
Research Development
170,679
170,679
123,860
134,389
75,420
Selling General and Administrative
970,105
970,105
852,754
785,620
672,609
Total Operating Expenses
1,099,014
1,099,014
964,489
894,018
735,401
Operating Income or Loss
1,257,187
1,257,187
1,105,996
1,038,988
755,055
Interest Expense
58,193
58,193
46,593
40,191
29,592
Income Before Tax
1,217,397
1,217,397
940,080
1,025,873
816,809
Income Tax Expense
95,495
95,495
84,725
102,512
63,114
Income from Continuing Operations
1,121,902
1,121,902
855,355
923,361
753,695
Net Income
1,121,902
1,121,902
855,355
923,361
753,695
Net Income available to common shareholders
1,121,902
1,121,902
855,355
923,361
753,695
Basic EPS
1.48
1.83
1.27
1.42
1.11
Diluted EPS
1.42
1.72
1.21
1.33
1.11
Basic Average Shares
650,826
614,710
673,221
651,801
677,874
Diluted Average Shares
681,930
650,433
708,140
695,359
677,874